Methods of treatment of mitochondrial disorders
Described is a method of treatment for a non-human mammal that has or is at risk of having mitochondrial disorder. The treatment comprises administering an effective amount of a compound of formula I wherein: R1 is OH, NHCOCH3, or NH2; R2 is H, CO2H, or formula II wherein: X is C1-C22 alkyl, C1-C22 alkenyl or C1-C22 alkynyl, with substituents selected from the group consisting of H, C1-3 alkyl, OH, NH2, and halogen, or wherein X is H; R3, R4 and R5 are independently, optionally substituted c1-c22 alkyl carbonyl, with substituents selected from the group consisting of C1-3 alkyl, OH, NH2 and halogen, or H wherein at least one of the R3, R4 and R5 is not H.